Novozymes A/S
CSE:NZYM B

Watchlist Manager
Novozymes A/S Logo
Novozymes A/S
CSE:NZYM B
Watchlist
Price: 403 DKK -3.93% Market Closed
Market Cap: 165.6B DKK
Have any thoughts about
Novozymes A/S?
Write Note

Operating Margin
Novozymes A/S

24.9%
Current
26%
Average
6.1%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
24.9%
=
Operating Profit
4.5B
/
Revenue
17.9B

Operating Margin Across Competitors

Country DK
Market Cap 165.6B DKK
Operating Margin
25%
Country US
Market Cap 86.5B USD
Operating Margin
16%
Country US
Market Cap 68B USD
Operating Margin
16%
Country JP
Market Cap 10.2T JPY
Operating Margin
29%
Country CH
Market Cap 36.4B CHF
Operating Margin
18%
Country CN
Market Cap 235.1B CNY
Operating Margin
11%
Country US
Market Cap 32.1B USD
Operating Margin
15%
Country US
Market Cap 27.8B USD
Operating Margin
13%
Country CH
Market Cap 25.9B EUR
Operating Margin
-4%
Country IN
Market Cap 2.2T INR
Operating Margin
17%
Country US
Market Cap 21.7B USD
Operating Margin
7%
No Stocks Found

Novozymes A/S
Glance View

Market Cap
165.6B DKK
Industry
Chemicals

Novozymes A/S, a beacon of innovation in biotechnology, operates at the intricate intersection of science and sustainability. Born from the storied roots of Novo Nordisk in 2000, this Danish company has carved out a niche in the enzyme and microbial sector. Novozymes’ core competency lies in its ability to harness the power of natural organisms, using them to drive forward industrial solutions that are not only efficient but also eco-friendly. The company’s extensive portfolio of enzymes transforms processes across a diverse array of industries, including agriculture, food and beverages, household care, and bioenergy. By engineering microorganisms to optimize yield and reduce waste, Novozymes provides solutions that both enhance product performance and support environmental goals. Revenue generation for Novozymes predominantly stems from its ability to innovate and provide proprietary solutions that businesses around the world rely on to gain a competitive edge. While enzymes in detergents simplify stain removal and enable energy-efficient washing at lower temperatures, in agriculture, Novozymes' biological solutions enhance crop yield by fostering nutrient absorption and pest resilience. This vast spectrum of applications showcases the company's deep integration into its clients' production processes, creating a stable demand. Novozymes capitalizes on its research and development prowess, ensuring a continuous flow of advanced, tailor-made bio-solutions, thereby securing long-term partnerships and a sustainable revenue stream from its global market presence.

NZYM B Intrinsic Value
124.53 DKK
Overvaluation 69%
Intrinsic Value
Price

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
24.9%
=
Operating Profit
4.5B
/
Revenue
17.9B
What is the Operating Margin of Novozymes A/S?

Based on Novozymes A/S's most recent financial statements, the company has Operating Margin of 24.9%.